Previous Article | Next Article ![]()
Journal of Virology, June 2001, p. 5263-5276, Vol. 75, No. 11
Max von Pettenkofer-Institut, Genzentrum, Ludwig
Maximilians Universität München, Munich,
Germany,1 and Department of Molecular
Biology, Massachusetts General Hospital, Harvard Medical School,
Boston, Massachusetts 021142
Received 28 April 2000/Accepted 3 March 2001
During synthesis and export of protein, the majority of the human
immunodeficiency virus type 1 (HIV-1) Env glycoprotein gp160 is
retained in the endoplasmic reticulum (ER) and subsequently ubiquitinated and degraded by proteasomes. Only a small fraction of
gp160 appears to be correctly folded and processed and is transported to the cell surface, which makes it difficult to identify negative sequence elements regulating steady-state surface expression of Env at
the post-ER level. Moreover, poorly localized mRNA retention sequences
inhibiting the nucleocytoplasmic transport of viral transcripts
interfere with the identification of these sequence elements. Using two
heterologous systems with CD4 or immunoglobulin extracellular/transmembrane domains in combination with the gp160 cytoplasmic domain, we were able to identify two membrane-distal, neighboring motifs, is1 (amino acids 750 to 763) and
is2 (amino acids 764 to 785), which inhibited surface
expression and induced Golgi localization of the chimeric proteins. To
prove that these two elements act similarly in the homologous context
of the Env glycoprotein, we generated a synthetic gp160 gene with
synonymous codons, the transcripts of which are not retained within the
nucleus. In accordance with the results in heterologous systems, an
internal deletion of both elements considerably increased surface
expression of gp160.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.11.5263-5276.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Identification of Two Sequences in the Cytoplasmic
Tail of the Human Immunodeficiency Virus Type 1 Envelope Glycoprotein
That Inhibit Cell Surface Expression
*
Corresponding author. Mailing address: Max von
Pettenkofer-Institut, Genzentrum, LMU München, Feodor-Lynen-Str.
25, 81377 Munich, Germany. Phone: 49 89 2180 6852. Fax: 49 89 2180 6899. E-mail: haas{at}lmb.uni-muenchen.de.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|